Robert Bradway | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Robert Bradway

Sort by

Viewing results 1‒20 of 20

Mergers & Acquisitions
M&A crackdown a ‘disaster’ for pharma sector, Pfizer executive warns
...Earlier at the conference, Amgen chief executive Robert Bradway expressed confidence his company would succeed in closing its acquisition of Horizon despite the FTC’s opposition....
May 17, 2023
Live news updates from December 12: Von der Leyen to push for EU ethics body, Microsoft to take 4% LSE stake
Amgen to buy Horizon Therapeutics for $28.3bn
...“The acquisition of Horizon is a compelling opportunity for Amgen . . . the potential new medicines in Horizon’s pipeline strongly complement our own R&D portfolio,” said Robert Bradway, chair and chief...
December 12, 2022
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Biotech
Amgen to buy Horizon Therapeutics for $28.3bn
...Robert Bradway, chair and chief executive of Amgen, said the acquisition of Horizon was a compelling opportunity for the company, which would expand the sale of its products in overseas markets, including...
December 12, 2022
Amgen Inc
Amgen boosts earnings guidance amid optimism for new cancer treatment
...Robert Bradway, chief executive, said: “With our newer products generating strong volume gains globally and many first-in-class medicines advancing through our pipeline, we are well positioned to serve patients...
July 30, 2019
Celgene Corp
Amgen to buy Celgene’s Otezla in $13.4bn deal
...Robert Bradway, Amgen chairman and chief executive, said the company was able to take advantage of an opportunity presented by industry consolidation....
August 26, 2019
Pharmaceuticals sector
Biotech Amgen reveals earnings beat in face of rising competition
...Robert Bradway, chairman and chief executive, said there was “strong, volume-driven growth” for new products....
April 30, 2019
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Pharmaceuticals sector
Amgen tops sales estimates, raises earnings guidance
...Amgen chief executive Robert Bradway said: “Our continued solid performance this quarter is yet another indication that we are on track to deliver on our long-term growth objectives....
July 25, 2017
FT SeriesM&A outlook
Drugmakers ‘flush with cash’ and hunting for deals
...“I think the smaller companies that have yet to generate sales or revenues are still very expensive relative to companies that have approved [drugs],” says Robert Bradway, chief executive of Amgen, the world...
January 24, 2018
News in-depthWeek in Review
Week in Review, January 27
...“I think the smaller companies that have yet to generate sales or revenues are still very expensive relative to companies that have approved [drugs],” said Robert Bradway, chief executive of Amgen, the world...
January 26, 2018
Pharmaceuticals sector
Amgen shares fall after quarterly sales miss expectations
...“We are working with payers to improve access to this important therapy for patients at risk for heart attacks and strokes,” said chief executive Robert Bradway....
April 26, 2017
US & Canadian companies
Regeneron shares tumble as US court blocks cholesterol drug
...“Protecting intellectual property is essential to our industry as it reinforces the incentives for the large and risky investments we make,” said Robert Bradway, Amgen’s chief executive....
January 6, 2017
US downturn
Amgen climbs after strong sales figures
...During an analyst meeting, Robert Bradway, chief executive of Amgen, said he was not convinced that splitting the company would add much value to shareholders, according to Michael Yee, an analyst at RBC...
October 28, 2014
fastFT
Amgen shares pop on trial results
...Robert Bradway, chief executive of Amgen, hailed the trial’s results, adding: Coupled with our recent U.S. regulatory submissions for ivabradine and talimogene laherparepvec and our upcoming regulatory...
August 4, 2014
fastFT
Amgen lifts outlook as it cuts workers
...Robert A. Bradway, the company’s chief executive, called the quarterly results “robust.”...
July 29, 2014
US equities
Offshore drillers sink after downgrade
...Robert Bradway, chief executive of Amgen, hailed the trial’s results, adding: “Coupled with our recent US regulatory submissions for ivabradine and talimogene laherparepvec and our upcoming regulatory submissions...
August 4, 2014
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
US equities
Rising sales and job cut plan boost Amgen
...Robert Bradway, the company’s chief executive, called the quarterly results “robust”....
July 30, 2014
Pharmaceuticals sector
Amgen’s $10.5bn takeover of Onyx approved by both boards
...“We believe that Amgen is strongly positioned to realize the full potential of Onyx’s portfolio and pipeline,” said Robert Bradway, Amgen chairman and chief executive officer....
August 25, 2013
InterviewThe Monday Interview
Lessons from corporate America
...Mr Sharer has handed the reins to Robert Bradway, whom he recruited from Morgan Stanley to be chief operating officer, and the company continues to ramp up its research spending in hopes of developing drugs...
December 9, 2012
Pharmaceuticals sector
Amgen snaps up Turkish generic drug group
...Robert Bradway, president and chief operating officer appointed last year, said: “Amgen is dedicated to making our innovative medicines available to patients in major markets around the world....
April 25, 2012
US & Canadian companies
Amgen chief executive to retire
...Robert Bradway, currently the company’s chief operating officer and president, will replace Mr Sharer next year....
December 15, 2011

Previous pagePage 1 of 1Next page